182 related articles for article (PubMed ID: 28025535)
1. Special Issue: New Approaches to Counteract Drug Resistance in Cancer.
Vasconcelos MH
Molecules; 2016 Dec; 22(1):. PubMed ID: 28025535
[TBL] [Abstract][Full Text] [Related]
2. Marine Natural Products as Models to Circumvent Multidrug Resistance.
Long S; Sousa E; Kijjoa A; Pinto MM
Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
[TBL] [Abstract][Full Text] [Related]
3. Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein.
Song JG; Lee YS; Park JA; Lee EH; Lim SJ; Yang SJ; Zhao M; Lee K; Han HK
Cancer Chemother Pharmacol; 2016 Oct; 78(4):735-44. PubMed ID: 27520631
[TBL] [Abstract][Full Text] [Related]
4. Relevance of multidrug resistance in the age of targeted therapy.
Türk D; Szakács G
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
[TBL] [Abstract][Full Text] [Related]
5. Classical resistance mechanisms.
Jäeger W
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):46-8. PubMed ID: 19203536
[No Abstract] [Full Text] [Related]
6. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
7. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.
Donnenberg VS; Donnenberg AD
J Clin Pharmacol; 2005 Aug; 45(8):872-7. PubMed ID: 16027397
[TBL] [Abstract][Full Text] [Related]
8. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
9. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
Yakisich JS; Venkatadri R; Azad N; Iyer AKV
J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
[TBL] [Abstract][Full Text] [Related]
10. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
11. Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells.
Tomono T; Yano K; Ogihara T
J Pharm Sci; 2017 Sep; 106(9):2642-2649. PubMed ID: 28322937
[TBL] [Abstract][Full Text] [Related]
12. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg JH; Broxterman HJ; Kool M; Assaraf YG; Peters GJ; Noordhuis P; Scheper RJ; Borst P; Pinedo HM; Jansen G
Cancer Res; 1999 Jun; 59(11):2532-5. PubMed ID: 10363967
[TBL] [Abstract][Full Text] [Related]
13. Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles.
Lopes-Rodrigues V; Di Luca A; Mleczko J; Meleady P; Henry M; Pesic M; Cabrera D; van Liempd S; Lima RT; O'Connor R; Falcon-Perez JM; Vasconcelos MH
Sci Rep; 2017 Mar; 7():44541. PubMed ID: 28303926
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of NPM reverses multidrug resistance in human hepatoma cells via inhibition of P-glycoprotein expression.
Luo F; Li H; Liang J; Jia H; Li X; Xiao H; He X; He J; Tian Y; Zhao H
Mol Med Rep; 2017 Apr; 15(4):2360-2368. PubMed ID: 28259962
[TBL] [Abstract][Full Text] [Related]
16. [Up-to-date approaches to clinical estimate of phenotype of multiple drug resistance associated with function of ABC-transporters in human solid tumors].
Bogush EA; Kirsanov VIu
Antibiot Khimioter; 2006; 51(9-10):50-5. PubMed ID: 18030792
[TBL] [Abstract][Full Text] [Related]
17. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.
Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M
Molecules; 2017 May; 22(6):. PubMed ID: 28587082
[TBL] [Abstract][Full Text] [Related]
18. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
Feng SL; Yuan ZW; Yao XJ; Ma WZ; Liu L; Liu ZQ; Xie Y
Pharmacol Res; 2016 Aug; 110():193-204. PubMed ID: 27058921
[TBL] [Abstract][Full Text] [Related]
19. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
20. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]